Dr. Cush ABSTRACT 898 Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled  Trial —missed RSSS outcome, but improved lung function #ACR18 @Rheumnow https://t.co/E7LdBEfXWc